Athens Medical C.S.A.'s latest marketcap:
As of 07/05/2025, Athens Medical C.S.A.'s market capitalization has reached $188.94 M. According to our data, Athens Medical C.S.A. is the 20550th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 188.94 M |
Revenue (ttm) | 317.73 M |
Net Income (ttm) | 2.09 M |
Shares Out | 86.74 M |
EPS (ttm) | 0.02 |
Forward PE | 0.00 |
Ex-Dividend Date | 07/22/2024 |
Earnings Date | 06/27/2025 |
Athens Medical C.S.A.'s yearly market capitalization.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
07/05/2025 | €188.94 M | 24.25% | 20550 |
12/31/2024 | €130.54 M | -18.43% | 21376 |
12/29/2023 | €160.03 M | 29.93% | 19559 |
12/30/2022 | €123.17 M | -15.98% | 20538 |
12/31/2021 | €146.58 M | 10.82% | 19934 |
12/31/2020 | €132.27 M | -27.73% | 17895 |
12/31/2019 | €183.01 M | 111% | 14651 |
12/31/2018 | €86.74 M | -31.51% | 17290 |
12/29/2017 | €126.63 M | 143.33% | 15899 |
12/30/2016 | €52.04 M | -1.64% | 18913 |
Company Profile
About Athens Medical C.S.A.
Athens Medical C.S.A., along with its subsidiaries, provides comprehensive healthcare services in Greece and internationally. Founded in 1983 and headquartered in Athens, Greece, the company delivers specialized medical treatments across multiple disciplines.
Key Services
- Oncology: Diagnosis and treatment for prostate, bladder, kidney, and testicular cancer.
- Cardiology & Cardiac Surgery: Interventional cardiology, electrophysiology, pediatric cardiology, and cardiac surgery.
- Robotic & Specialty Surgery: General, gynecologic, and urology robotic surgeries, as well as neuro- and spine surgery.
- Orthopedics & Sports Medicine: Treatment for foot, ankle, hand, wrist, hip, knee, shoulder, and spine conditions, including sports injuries.
- Plastic & Bariatric Surgery: Face, body, breast, obesity, reconstructive, and sex reassignment surgeries, along with gastric banding and sleeve gastrectomy.
- Chronic Disease Management: Care for diabetes, endocrinology, heart failure, hypertension, pain, respiratory issues, stroke, and thyroid disorders.
Additional Offerings
The company also operates wellness and prevention centers while providing medical education, training, and practice services to healthcare professionals.
Frequently Asked Questions
-
What is Athens Medical C.S.A.'s (ATH-IATR) current market cap?As of 07/05/2025, Athens Medical C.S.A. (including the parent company, if applicable) has an estimated market capitalization of $188.94 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Athens Medical C.S.A. (ATH-IATR) rank globally by market cap?Athens Medical C.S.A. global market capitalization ranking is approximately 20550 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.